Lipids and schizophrenia: Editorial

British Journal of Psychiatry

Volumn 174, Issue FEB., 1999, Pages 101-104

  Walker, Nicholas P ^a   Fox, Helen C ^a   Whalley, Lawrence J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; FATTY ACID METABOLISM; NERVE CONDUCTION; NERVE MEMBRANE; PATHOPHYSIOLOGY; SCHIZOPHRENIA; BRAIN LEVEL; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; LIPID METABOLISM; METABOLISM; NERVOUS SYSTEM; NEUROLOGIC DISEASE;

BRAIN CHEMISTRY; HUMANS; LIPID METABOLISM; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; SCHIZOPHRENIA;

EID: 0033070506     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.174.2.101     Document Type: Editorial

References (30)

1. 1 formation in blood platelets from patients with depression, mania and schizophrenia. British Journal of Psychiatry, 127, 591-595.
2. Albers, M., Meurer, H., Marki, F., et al (1993) Phospholipase A2 activity in serum of neuroleptic-naive psychiatric inpatients. Pharmacopsychiatry, 26, 94-98.
3. Brown, A. J., Pang, E. & Roberts, D. C. K. (1991) Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n-3 polyunsaturated fatty acids: study design implications. American Journal of Clinical Nutrition, 54, 668-673.
4. Carlson, S. E., Carver, J. D. & House, S. G. (1986) High fat diets varying in ratios of polyunsaturated to saturated fatty acid and linolenic acid: a comparison of rat neural and red cell membrane phospholipids. Journal of Nutrition, 116, 718-725.
5. Crawford, M. A. (1993) The role of essential fatty acids in neural development: implications for perinatal nutrition. American Journal of Clinical Nutrition, 57 (suppl.), 703-710.
6. Duthie, S. J., Ma, A., Ross, M. A., et al (1996) Antioxidant supplementation decreased oxidative DNA damage in human lymphocytes. Cancer Research, 56, 1291-1295.
7. Fischer, S., Kissling, W. & Kuss, H. J. (1992) Schizophrenic patients treated with high dose phenothiazine or thioxanthene become deficient in polyunsaturated fatty acids in their thrombocytes. Biochemical Pharmacology, 44, 317-323.
8. Gattaz, W. F., Kollisch, M., Thuren, T., et al (1987) Increased plasma phospholipase-a2 activity in schizophrenic patients: reduction after neuroleptic therapy. Biological Psychiatry, 22, 421-126.
9. Glen, A. I., Glen, E. M., Horrobin, D. F., et al (1994) A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases. Schizophrenia Research, 12, 53-61.
10. Hess, D. T., Patterson, S. I., Smith, D. S., et al (1993) Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature, 366, 562-565.
11. Horrobin, D. F. (1977) Schizophrenia as a prostaglandin deficiency disease. Lancet, i, 936-937.
12. _, Manku, M. S., Hillman, H., et al (1991) Fatty acid levels in the brains of schizophrenics and normal controls. Biological Psychiatry, 30, 795-805.
13. Hudson, C. J., Kennedy, J. L., Gotowiec, A., et al (1996) Genetic variant near cytosolic phospholipase a2 associated with schizophrenia. Schizophrenia Research, 21, 111-116.
14. Huttenlocher, P. (1979) Synaptic density in human frontal cortex, developmental changes and effects of ageing. Brain Research, 163, 195-205.
15. Jones, P. & Murray, R. M. (1991) The genetics of schizophrenia is the genetics of neurodevelopment. British Journal of Psychiatry, 158, 615-623.
16. Lucas, A., Morley, R., Cole, T. J., et al (1992) Breast milk and subsequent intelligence quotient in children born preterm. Lancet, 339, 261-264.
17. Makrides, M., Neumann, M. A., Byard, R. W., et al (1994) Fatty acid composition of brain, retina and erythrocytes in breast- and formula-fed infants. American Journal of Clinical Nutrition, 60, 189-194.
18. McCreadie, R. G., MacDonald, E., Wiles, D., et al (1995) The Nithsdale schizophrenia surveys. XIV: Plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia and in normal subjects. British Journal of Psychiatry, 167, 610-617.
19. McGill, H. C., Mott, G. E., Lewis, D. S., et al (1996) Early determinants of adult regulation, effects of infant nutrition on adult lipid and lipoprotein metabolism. Nutrition Reviews, 54 (suppl), 31-40.
20. Mellor, J. E., Laugharne, J. D. E. & Peet, M. (1996) Omega-3 fatty acid supplementation in schizophrenic patients. Human Psychopharmacology, II, 39-46.
21. Moser, H. W. (1993) Lorenzo oil therapy for adrenoleukodystrophy: a prematurely amplified hope. Annals of Neurology, 34, 121-122.
22. Negre-Aminou, P., Nemenoff, R. A., Wood, M. R., et al (1996) Characterization of phospholipase A2 activity enriched in the nerve growth cone. Journal of Neurochemistry, 67, 2599-2608.
23. Peet, M., Laugharne, J. D., Horrobin, D. F., et al (1994) Arachidonic acid: a common link in the biology of schizophrenia? [Letter]. Archives of General Psychiatry, 51, 665-666.
24. Pettegrew, J. W., Keshavan, M. S., Panchalingam, K., et al (1991) Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Archives of General Psychiatry, 48, 563-568.
25. Price, S., Fox, H., St Clair, D., et al (1997) Lack of association between schizophrenia and a polymorphism close to the cytosolic phospholipase A2 gene. Psychiatric Genetics, 7, 111-114.
26. Puri, B. K., Steiner, R. & Richardson, A. J. (1998) Sustained remission of positive and negative symptoms of schizophrenia following treatment with eicosapentaenoic acid. Archives of General Psychiatry, 55, 188-189.
27. Ross, B. M., Hudson, C., Erlich, J., et al (1997) Increased phospholipid breakdown in schizophrenia, evidence for the involvement of a calcium-independent phospholipase A2. Archives of General Psychiatry, 54, 487-494.
28. Smalheiser, N. R., Dissanayake, S. & Kapil, A. (1996) Rapid regulation of neurite outgrowth and retraction by phospholipase A2-derived arachidonic acid and its metabolites. Brain Research, 721, 39-48.
29. Stanley, J. A., Williamson, P. C., Drost, D. J., et al (1995) An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Archives of General Psychiatry, 52, 399-406.
30. Whalley, L. J., Christie, J. E., Blackwood, D. H. R., et al (1989) Disturbed endocrine function in the psychoses, disordered homeostasis or disease process. British Journal of Psychiatry, 155, 455-461.